Startseite How are opioids used in Norway? Persistent use, utilization of depot formulation and age profile in non-palliation patients
Artikel Öffentlich zugänglich

How are opioids used in Norway? Persistent use, utilization of depot formulation and age profile in non-palliation patients

  • Kristian Svendsen , Petter Borchgrevink , Olav Magnus Fredheim und Svetlana Skurtveit
Veröffentlicht/Copyright: 1. Juli 2010
Veröffentlichen auch Sie bei De Gruyter Brill

Objectives

The extent of persistent opioid use in Norway is unknown. We have studied how many persistent opioid users there are in Norway, whether they use long- or short acting opioids and the age distribution of these patients.

Methods

We have used the Norwegian prescription database containing all drugs dispensed since 2004. We have created three definitions of persistent opioid use corresponding to different clinical settings. The tree definitions are based on amount of opioid dispensed, frequency of dispensing and distribution of dispensing throughout the year. We will present 2008 data of non cancer patients. These three patient groups are: (1) Wide: opioids are used on and off throughout the year in at least half the days. (2) Intermediary: opioids are used on average every day throughout the year. (3) Strict: opioids are used continuously every day in high doses throughout the year.

Results

There are 421,724 non-persistent opioid users in 2008. There are 24,462, 14,132 and 6547 in settings 1, 2 and 3 respectively. These numbers account for 8.90, 0.52, 0.30 and 0.14% of the Norwegian population. Together the three groups of patients account for 45,141 persistent opioid users (0.95% of the population). The percentage of users who use mainly long acting opioids (>80%) is; 2.7%, 9.7%, 16.0% and 36.9% for non-persistent users, groups 1, 2 and 3 respectively. The age of opioid users was studied. The percentage under 30 years old was 14.6%, 2.3%, 2.1% and 3.3% for non-persistent users and groups 1, 2 and 3 respectively. Over 60 years old the percentages are 36.0%, 53.0%, 46.1% and 33.1% respectively.

Conclusion

Less than 10% of people using opioids in 2008 are persistent users. Young people use opioids less persistently. There is a correlation between increased degree of persistence and increased use of long acting opioids.

Published Online: 2010-07-01
Published in Print: 2010-07-01

© 2010 Scandinavian Association for the Study of Pain

Artikel in diesem Heft

  1. Editorial comment
  2. Functional brain imaging of acute postoperative pain
  3. Clinical pain research
  4. Brain activation due to postoperative pain from the right hand measured with regional cerebral blood flow using positron emission tomography
  5. Editorial comment
  6. Long-term low-dose transdermal buprenorphine therapy for chronic noncancer pain
  7. Original experimental
  8. A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids
  9. Editorial comment
  10. Repeated nociceptive stimulation for detecting drug effects
  11. Original experimental
  12. The effects of gabapentin in human experimental pain models
  13. Editorial comment
  14. Whether the weather influences pain: High prevalence of chronic pain in Iceland and Norway: Common genes? Or lack of sunshine and vitamin D?
  15. Observational studies
  16. A population based study of the prevalence of pain in Iceland
  17. Editorial comment
  18. Swedish nurses are prone to chronic shoulder and back pain because of miserable working conditions and poor leadership?
  19. Observational studies
  20. Predicting of pain, disability, and sick leave regarding a non-clinical sample among Swedish nurses
  21. Abstracts
  22. Trigeminal neuralgia or odontogenic pain
  23. Abstracts
  24. What’s wrong with animal models of pain?
  25. Abstracts
  26. Immunotherapy for neuroblastoma elicits a complement dependent whole body allodynia
  27. Abstracts
  28. Pain mechanisms in animal models of rheumatoid arthritis
  29. Abstracts
  30. Translating basic research to pharmacological treatment of neuropathic pain
  31. Abstracts
  32. Free Poster Presentations: Forearm heat pain does not inhibit electrically induced tibialis anterior muscle pain
  33. Abstracts
  34. Offset analgesia evoked by non-contact thermal stimulator
  35. Abstracts
  36. Inhibition of FAAH reverses spinal LTP
  37. Abstracts
  38. Hyperexcitable C-nociceptors in human paroxysmal pain
  39. Abstracts
  40. Pain sensitivity and experimentally induced sensitization in red haired women
  41. Abstracts
  42. How are opioids used in Norway? Persistent use, utilization of depot formulation and age profile in non-palliation patients
  43. Abstracts
  44. To which extent does incident and persistent use of weak opioids predict problematic opioid use?
  45. Abstracts
  46. Is transdermal buprenorphine for chronic non-malignant pain used long term without co-medication with other potentially addictive drugs?
  47. Abstracts
  48. Prostaglandin E2 production in synovial tissue and acute postoperative pain after knee arthroscopy
  49. Abstracts
  50. Girl presenting with oesophageal spasm pain after fundoplication
  51. Abstracts
  52. Epidemiology of persistent postoperative pain: Association of persistent pain and sensory abnormalities
  53. Abstracts
  54. Cost–benefit of a 13-week multidiciplinary rehabilitation course for chronic non-malignant pain patients
  55. Abstracts
  56. A novel and effective treatment modality for medically unexplained pain
  57. Abstracts
  58. Somatocognitive therapy in the management of chronic gynaecological pain. A review of current approach and historical background
  59. Abstract
  60. The Manual Intervention Trial (MINT)—The effect of various combinations of naprapathic manual therapy. The study protocol of a randomized controlled trial
  61. Abstracts
  62. The experience of chronic pain, loss and grief
  63. Abstracts
  64. Effect of buprenorphine and fentanyl in experimental induced superficial, deep and hyperalgesic pain
  65. Abstract
  66. Pretreatment with opioids enhances afferent induced long-term potentiation in the rat dorsal horn
  67. Abstracts
  68. Pigs in pain—Porcine behavioural responses towards mechanical nociceptive stimulation directed at the hind legs
  69. Abstracts
  70. A human experimental bone pain model
Heruntergeladen am 2.10.2025 von https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2010.05.013/html
Button zum nach oben scrollen